|
2022 Other Outputs Preclinical development of complement C5aR1 antagonists for the treatment of inflammatory bowel diseaseCui, Shuai (2022). Preclinical development of complement C5aR1 antagonists for the treatment of inflammatory bowel disease. PhD Thesis, School of Biomedical Sciences, The University of Queensland. doi: 10.14264/3a8be04 |
